BIM
NVO

Bogle Investment Management’s Novo Nordisk NVO Stock Holding History

Bogle Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-93,876
Closed -$3.26M – 227
2020
Q3 		$3.26M Sell
93,876
-47,772
-34% -$1.59M 0.96% 23
2020
Q2 		$4.64M Buy
+141,648
New +$4.52M 0.77% 26
2020
Q1 		– Sell
-68,244
Closed -$1.98M – 329
2019
Q4 		$1.98M Buy
+68,244
New +$1.89M 0.18% 141

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Bogle Investment Management's NVO Position: Q4 2020 in Review

Bogle Investment Management sold out of Novo Nordisk (NVO) in Q4 2020, closing a stake of 93,876 shares — an estimated $3.26M sold.

Bogle Investment Management first reported a position in NVO in Q4 2019 and held it in 3 quarters. The position peaked at $4.64M in Q2 2020. 702 funds tracked by Wall St. Rank hold NVO as of Q4 2020.

  • Bogle Investment Management reported no remaining Novo Nordisk position as of Q4 2020 after selling out during the quarter.
  • Bogle Investment Management sold 93,876 Novo Nordisk shares in Q4 2020, an estimated $3.26M.
  • Bogle Investment Management first reported a position in Novo Nordisk in Q4 2019 and held it in 3 quarters.
  • Bogle Investment Management's Novo Nordisk position peaked at $4.64M in Q2 2020.
  • 702 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.